Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- The Wall Street Journal: Boy Scouts of America looks to bankruptcy as membership falls, lawsuits mount - December 12, 2018
- Asia Markets: Asia stocks rally into a second day with Hong Kong markets in the lead - December 12, 2018
- To prevent sexual assault, start with teaching more about sex, educators say - December 12, 2018